The crosstalk between photoperiod and early mild stress on juvenile oscar (Astronotus ocellatus) after acute stress.

Early mild stress (EMS) is like preparedness and might help fish deal with stress appropriately. This study investigated how EMS and photoperiod changes can impact growth, haematology, blood biochemistry, immunological response, antioxidant system, liver enzymes, and stress response of oscar (Astronotus ocellatus; 7.29 ± 0.96 g) before and after acute confinement stress (AC stress). Ten experimental treatments included five different photoperiods 8L16D (08:16 light to dark), 12L12D (12:12 light to dark), 16L8D (16:08 light to dark), 20L4D (20:04 light to dark), and 24L0D (24:00 light to dark), and these five photoperiod schedules were conducted in an EMS condition. After 9 weeks, no significant differences were found in growth parameters, survival rate, and body composition. At the end of the experiment and after AC stress, fish farmed in 24 light hours had the lowest haematocrit, white blood cells, total protein, blood performance, lysozyme, immunoglobulin M, complement C3, superoxide dismutase, and catalase. Fish that experienced EMS had significantly higher survival rates than those farmed in normal conditions (80.67% vs 61.33%). In conclusion, considering all measured parameters, 8-h light can be suggested as an optimum photoperiod for this fish species. Under 24L0D (no EMS) conditions, there were many negative effects apparent. In addition, a positive effect of EMS was evident in terms of survival after AC stress. AC stress decreased some health parameters under 24-h light treatment, while these results were not observed in EMS-exposed fish. Therefore, the EMS schedule can be a useful tool in preventing the negative effects of stress.

Fish Meal Replacement and Early Mild Stress Improve Stress Responsiveness and Survival of Fish after Acute Stress.

Stress responsiveness and fish meal (FM) replacement are two of the most important concerns toward achieving sustainable aquaculture. The purpose of this study was to see how early mild stress (netting) and FM replacement with meat and bone meal (MBM) affected oscar (Astronotus ocellatus; 5.2 ± 0.9 g) growth, hematology, blood biochemistry, immune responses, antioxidant system, liver enzymes, and stress responses. Oscars were subjected to a 3 × 3 experimental design (three fish meal replacement levels: 250, 180 and 110 g/kg of FM in diets; three stress periods: 0-, 2- and 3-times early mild stress). After ten weeks of the experiment, FM levels in diets did not affect growth data, but the survival rate after the acute confinement (AC) stress was lower in 11FM treatments (47.7% compared to 67.7%) than others. Fish exposed to the 3Stress schedule had a lower growth (31.03 ± 6.50 g) and survival rate (55.5%) after the AC stress than the 2Stress group (38.92 ± 6.82 g and 70.0%). Lower survival and growth rate in the 3Stress and 11FM groups coincided with the lowest blood performance, total protein, lysozyme, complement C4, complement C3, immunoglobulin, superoxide dismutase, catalase, glutathione peroxidase, and the highest glucose, cortisol, low-density lipoprotein and aspartate aminotransferase serum levels. Altogether, this study revealed that it is possible to replace FM with MBM up to 28% (180 g/kg of FM) without negative effects on the growth and health of juvenile oscar as dietary 110 g/kg of FM impaired fish health. While fish welfare should be considered, we can conclude that mild stress (2Stress) during the farming period, but without adding excessive alternative protein sources, can improve the stress responsiveness of oscar.

Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer.

The transcription factor nuclear factor-κB (NF-κB) is a critical regulator of the immune response, inflammation, cell growth, and survival. Canonical and non-canonical pathways, two NF-κB pathways, are activated through diverse stimulators and receptors. NF-κB activity is dysregulated in various inflammation-related diseases and cancers. It was found that the persistent NF-κB activity has a major role in proliferation, apoptosis inhibition, metastasis, and cell cycle disruption in cancer cells and also the survival of cancer stem cells (CSCs) within the tumors. Therefore, suppression of the NF-κB pathway could be a promising therapeutic target for cancer therapy. Different biological inhibitors (e.g., peptides, small molecules, antisense oligonucleotides (ASOs), and antibodies (Abs)) have been demonstrated to inhibit the NF-κB pathway. Low stability in the circulation system, weak availability, and poor cellular uptake of some inhibitors limit their therapeutic applications. To address these drawbacks nanocarrier systems are often formulated and applied in drug delivery as an effective therapeutic approach. Targeted nanosystems (i.e., small molecules, peptides, Abs and Aptamers (Aps) conjugated nanocarriers), as well as smart responsive nanocarriers, can improve the efficiency of therapeutics while reducing the off-target toxicity. This review describes the NF-κB signaling pathways and mechanisms of their over-activation in tumor initiation and progression. The NF-κB inhibitors and their clinical applications are also discussed. It also overviews different nanocarriers used as robust vehicles for the delivery of NF-κB inhibitors and anti-tumor agents to improve the bioavailability of drugs and selective targeting of cancer cells to repress NF-κB activity in tumor cells.